STOCK TITAN
  1. Home
  2. Sec-filings
  3. MTVA
  4. [EFFECT] MetaVia Inc. SEC Filing

[EFFECT] MetaVia Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 15, 2026 9:00 A.M.
Form: S-1
CIK: 0001638287
Company Name: MetaVia Inc.
File Number: 333-292581

Source: View Original Filing on SEC EDGAR

Stock MTVA logo
MetaVia Inc

NASDAQ:MTVA

MTVA Rankings

#6124 Ranked by Market Cap
N/A Ranked by Dividends

MTVA Latest News

Jan 16, 2026
MetaVia Announces the Closing of $9.3 Million Underwritten Public Offering, Including Full Exercise of Allotment Option
Jan 5, 2026
MetaVia Reports Positive Statistically Significant Results from Its Phase 1b Clinical Trial of DA-1726 In Metabolic Disease - Demonstrating Strong Glycemic Response, Significant Direct Hepatic Effects, Robust Weight Loss and Favorable Safety Profile
Dec 29, 2025
MetaVia to Participate in and Sponsor the 10th Annual MASH-TAG 2026 Conference
Dec 22, 2025
MetaVia Regains Compliance with Nasdaq Minimum Bid Price Requirement
Dec 2, 2025
MetaVia Inc. Announces 1-for-11 Reverse Stock Split

MTVA Latest SEC Filings

Jan 16, 2026
[8-K] MetaVia Inc. Reports Material Event
Jan 16, 2026
[424B4] MetaVia Inc. Prospectus Filed Pursuant to Rule 424(b)(4)
Jan 12, 2026
[S-1/A] MetaVia Inc. Amends IPO Registration Statement
Nov 26, 2025
[8-K] MetaVia Inc. Reports Material Event
Nov 7, 2025
[8-K] MetaVia Inc. Reports Material Event

MTVA Stock Data

16.53M
1.04M
62.56%
6.36%
0.5%
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE